Indeed, elevated expression of HER3 has been shown to play a pivotal role in the development of HER2-overexpressing breast cancer [9, 10], castration-resistant prostate cancer (CRPC) [11], and ovarian cancer [12, 13]. The gene discussed is ERBB2; the disease is breast carcinoma.